MONDAY, Jan. 7, 2019 -- For patients with secondary progressive Multiple Sclerosis (SPMS), treatment with rituximab is associated with a significantly lower Expanded disability Status Scale (EDSS) score and delayed progression, according to a study... (Source: - Pharma News)

MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log on with your social media account. 100% free.

Read full article on


Follow Us on Twitter

Follow Us On Twitter - Image